Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-06-07

FDA Approved: TINDAMAX — Supplemental Application (Mission Pharmacal Company)

View source ↗

Summary

FDA approved a supplemental application for TINDAMAX (tinidazole) to update the labeling, including expansion of indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TINDAMAX (Tinidazole)

Snippet

SUPPL AP for TINDAMAX (TINIDAZOLE)